Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.
What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...
Pune reported a suspected Guillain Barre Syndrome death on Friday, a fortnight since the last casualty due to the disease. The 38-year-old man is a resident of Manjari on Pune Solapur road and was ...
Individuals with chronic neurological disorders including motor neuron disease (MND), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN) were at ...
Guillain-Barre Syndrome (pronounced Gee-luhn-Baa Syndrome) or GBS is a rare autoimmune condition in which the immune system attacks the peripheral nerves. It leads to symptoms such as numbness ...
Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting Targeted for 1H 2025 Ahead of Planned Biologics License ...
“We have seen patients where they don’t know what the trigger was, but most often you typically hear about the preceding infection of some kind,” said Donna Hartlem, the executive director of GBS/CIDP ...
The full GBS Patient Registry Report is available here.You can watch recordings of this year's State of the Science meetings here. For more information, please visit www.gbs-cidp.org or contact ...